Hodgo

$PAA - doggy spec biotech basing up.

ASX:PAA   PHARMAUST LIMITED
after the pump through 19 recently this thing has come back and tested support. Id suggest clearly not being bought up by funds. However, looking much better for a test of resistance on the hourly at 22.5c.

From the recent presentation, the next move was to test their drug against human lung tissue to test its impact on covid infected cells.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。